Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingFundraise23 Oct 2026

Neo Infracon Ltd

Pursuant to the Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are pleased to inform you that the Meeting of the Board of Directors of Neo Infracon Limited held today i.e. Friday, 23rd October, 2026 through Video Conferencing, has considered and approved the following matters: 1.As recommended by the Audit Committee at its meeting held on 23-October-2026, the Board considered and approved the proposed ....

Neo Infracon Ltd held a board meeting on October 23, 2026, where they approved a capital contribution to a partnership firm, NeoVenture, with a 54% profit and loss sharing ratio. The terms are fair and not prejudicial to the company's interests.

Read more →📎 1 attachment
BSECompany UpdateFundraise23 Oct 2026

Info Edge (India) Ltd

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Info Edge (India) Ltd has agreed to make a primary investment of about Rs. 5 crores in Bizcrum Infotech Private Limited (Bijnis) through its wholly-owned subsidiary Startup Investments (Holding) Ltd. The investment is part of a larger financing round involving existing and new investors.

Read more →📎 1 attachment
NSEAcquisitionFundraise23 Oct 2026

Info Edge (India) Limited

Acquisition

Info Edge (India) Limited has informed the Exchange about Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company's wholly-owned subsidiary, Startup Investments (Holding) Ltd., has agreed to make a primary investment of about Rs. 5 crores in Bizcrum Infotech Private Limited (‘Bijnis’) and may undertake a secondary acquisition of equity shares of Bijnis from an existing investor.

Read more →📎 1 attachment
BSECompany UpdateFundraise23 Oct 2026

Pasupati Fincap Ltd

Fintellectual Corporate Advisors Pvt. Ltd. ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer Advertisement under Regulation 18 (12) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended to the Shareholder(s) of Pasupati Fincap Ltd ("Target Company").

Pasupati Fincap Ltd has received a post-offer advertisement from Fintellectual Corporate Advisors Pvt. Ltd. regarding the open offer for acquisition of 12,22,000 fully paid-up equity shares from the shareholders of Pasupati Fincap Ltd by Uday Narang.

Read more →📎 1 attachment
BSECompany UpdateFundraise23 Oct 2026

Regency Fincorp Ltd

Submission of Intimation of Issuance of Listed Rated Secured Non Convertible Debenture on private placement basis.

Regency Fincorp Ltd has issued 40,000 units of Secured, Rated, Listed, Non-Convertible Debentures on private placement basis, aggregating to INR 40,00,00,000. The debentures have a face value of INR 10,000 and a 14% interest rate. The company has also appointed Catalyst Trusteeship Limited as Trustee and Credora Partners Private Limited as Merchant Banker for the issuance.

Read more →📎 1 attachment
NSEOutcome of Board MeetingFundraise23 Oct 2026

Vaswani Industries Limited

Outcome of Board Meeting

Vaswani Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on October 23, 2026, where the Board of Directors approved the allotment of 16,45,000 fully paid-up equity shares at a price of Rs. 60/- per Equity Share, including a share premium of Rs. 50/- per Equity Share, to the Promoter Category.

Read more →📎 1 attachment
NSEMonitoring Agency ReportFundraise23 Oct 2026

Sterlite Technologies Limited

Monitoring Agency Report

Sterlite Technologies Limited has received a Monitoring Agency Report for the quarter ended September 30, 2026, from CARE Ratings Limited, regarding the utilization of proceeds from its QIP issue worth Rs. 1500 crore.

Read more →📎 1 attachment
NSEMonitoring Agency ReportFundraise23 Oct 2026

Sterlite Technologies Limited

Monitoring Agency Report

Sterlite Technologies Limited has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended September 30, 2026, related to the utilization of proceeds from a Preferential Issue of convertible warrants worth Rs. 498.30 crore.

Read more →📎 1 attachment
NSEGeneral UpdatesFundraise23 Oct 2026

Tata Communications Limited

General Updates

Tata Communications Limited has issued and allotted Commercial Paper aggregating to an amount of ₹300 crore, with details as below: Description of the security Commercial Paper, Size of the issue ₹300 crore, Date of Issue October 22, 2026, Date of Redemption November 23, 2026, Face Value per security ₹5,00,000/-, Discount Rate 6.75% p.a., ISIN INE151A14370. The said Commercial Paper is listed on National Stock Exchange of India Limited on October 23, 2026.

Read more →📎 1 attachment
BSECompany UpdateFundraise23 Oct 2026

Godrej Consumer Products Ltd

The attached file is self explanatory

Godrej Consumer Products Ltd has announced the basis of allotment of equity shares to various categories of investors, including QIBs, retail investors, and employees, as part of its public issue. The company has allotted 2,253,125 equity shares to 33,948,557 applicants, with a subscription ratio of 1:1. The issue was subscribed to the extent of 4.37806 times. The company has also allotted 149,088,220 equity shares to anchor investors at the offer price of ₹151 per equity share, representing 60% of the QIB portion.

Read more →📎 1 attachment
NSEUpdatesFundraise23 Oct 2026

Medicamen Biotech Limited

Updates

Medicamen Biotech Limited has informed the exchange about the outcome of the meeting of the Preferential Issue Committee of its Board of Directors, which has approved the allotment of 5,00,000 equity shares to a promoter entity at an issue price of Rs. 530 per share, increasing the company's paid-up equity share capital to Rs. 14,06,28,150.

Read more →📎 1 attachment
BSECompany UpdateFundraise23 Oct 2026

Medicamen Biotech Ltd-$

Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to conversion of 5,00,000 fully convertible warrants at an issue price of Rs. 530/- per Equity Share

Medicamen Biotech Ltd has approved the allotment of 5,00,000 equity shares at Rs. 530/- per share to a promoter group entity, Shivalik Rasayan Limited, for an aggregate amount of Rs. 26,50,00,000/-, increasing the company's paid-up equity share capital to Rs. 14,06,28,150/-.

Read more →📎 1 attachment
BSEBoard MeetingFundraise23 Oct 2026

Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the allotment of unlisted Non-convertible Cumulative Redeemable Preference share(NCRPS) on private placement basis.

Chemiesynth (Vapi) Ltd has scheduled a board meeting on 28/10/2026 to consider the allotment of unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis.

Read more →📎 1 attachment
← PreviousPage 49 of 300Next →